- 全部删除
 
您的购物车当前为空
GPRC5D Protein, Human, Recombinant, Fluorescent is expressed in HEK293 mammalian cells. The predicted molecular weight is 65.81 kDa and the accession number is Q9NZD1.

| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 5 μg | ¥ 1,880  | 6-8日内发货 | |
| 10 μg | ¥ 3,170  | 6-8日内发货 | |
| 20 μg | ¥ 5,330  | 5日内发货 | |
| 50 μg | ¥ 7,730  | 5日内发货 | |
| 100 μg | ¥ 12,200  | 5日内发货 | |
| 200 μg | ¥ 16,800  | 5日内发货 | |
| 500 μg | ¥ 39,200  | 5日内发货 | 
| 生物活性 | Immobilized  Human GPRC5D-VLP(Full Length) Protein, Fluorescent  at 5 μg/mL (100 μL/well) can bind Anti-Human GPRC5D Antibody, Human IgG1the EC50 is 5-60ng/mL.  | 
| 产品描述 | GPRC5D Protein, Human, Recombinant, Fluorescent is expressed in HEK293 mammalian cells. The predicted molecular weight is 65.81 kDa and the accession number is Q9NZD1.  | 
| 种属 | Human  | 
| 表达系统 | HEK293 Cells  | 
| 标签 | GFP | 
| 蛋白编号 | Q9NZD1 | 
| 别名 | GPRC5D  | 
| 蛋白构建 | A DNA sequence encoding the human GPRC5D (Q9NZD1) (Met1-Val345) was expressed. This protein carries a GFP tag. Predicted N terminal: Met 1  | 
| 分子量 | 65.81 kDa (predicted) | 
| 内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. | 
| 蛋白性状 | Solution | 
| 缓冲液 | Supplied as sterile 50 mM Hepes, 150 mM NaCl, 10% Trehalose, pH 7.2. | 
| 存储 | It is recommended to store the product under sterile conditions at -70°C or lower. Samples are stable for up to 12 months at -80°C. Please avoid multiple freeze-thaw cycles and store products in aliquots.  | 
| 运输方式 | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. | 
| 研究背景 | Orphan G-protein-coupled receptor family C group 5 member D (GPRC5D) has seven transmembrane segments forming the core of the receptor, as well as an intracellular C-tail and an extracellular N-terminal domain. GPRC5D is highly and selectively expressed on the surface of CD138+ multiple myeloma (MM) cells, whereas in normal tissues, a much lower expression is limited to plasma cells and certain hard keratinizing tissues. This makes GPRC5D a promising marker for monitoring tumor load and a target antigen for MM-specific T cell-engaging therapies such as bispecific antibodies and CAR-T cells.  |